Orion Genomics develops oncology diagnostic products for cancer screening and therapy selection. The company identifies epigenetic biomarkers and employesmthem in the development of novel molecular diagnostic tests to find breast, lung, ovarian, colorectal and other common cancers. Additionally, Orion Genomics discovers biomarkers that can aid in the selection of best therapies for cancer patients.